Labs that violate H1N1 norms may face action
So far, 100 people have been hospitalised with H1N1 cases and two people have died in Bengaluru due to the virus attack which is also called as swine flu.

The move to take punitive action against private labs comes in the wake of conflicting reports of H1N1 cases in Bengaluru compiled by the Bruhat Bengaluru Mahanagara Palike (BBMP) and the State Health and Family Welfare Department. The number of H1N1 cases that the BBMP has been releasing has been much higher than the health department’s data.
So far, 100 people have been hospitalised with H1N1 cases and two people have died in Bengaluru due to the virus attack which is also called as swine flu. The total number of confirmed cases reported in the state is 456 and the total death toll is six.
BBMP collates data for its disease datasheet from test reports submitted by a lab - private and government, whereas the Health and Family Welfare Department considers cases reported by five of the accredited laboratories of Bengaluru.
According to the health department, only five hospitals — two government and three private — Nimhans, National Institute of Virology, Narayana Nethralaya, Manipal Hospital and Commando Hospital are permitted to do the testing. But there are at least 21 other private laboratories that do H1N1 testing and the results are then submitted to the BBMP through private hospitals.

“But the problem with acknowledging the test reports from random private laboratories is the standards and procedures they adopt. Also, often these private laboratories test the throat swab of the patient even if the patient belongs to category A or B of influenza. Whereas, the GoI and WHO guidelines advise lab testing only for category C patients,” said Dr S Sajjan Shetty, joint director, National Vector Borne Disease Control Programme, State Health and Family Welfare Department. “Positive results of patients who are category A and B cannot be considered as confirmed cases, they are only suspected cases”.
According to government guidelines, only patients suspected with type C of H1N1 virus should be hospitalised, where as those with type A and B should be treated as suspects and provide adequate observation and medication.
To streamline the system, the department has asked 21 private laboratories to submit an application to the Nimhans (apex laboratory) director seeking permission to conduct the tests. “An inspection will take place to ensure that the laboratory has RTPCR equipment for testing. Once the permission is given, the laboratories can function,” Shetty said.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.